See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2019_Zyla_Life_Sciences.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001586105')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 54,517,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,281,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,059,000 |
| 3 | remainder_Assets | 2,076,000 |
| 4 | LiabilitiesCurrent | 33,145,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,079,000 |
| 9 | ResearchAndDevelopmentExpense | 3,536,000 |
| 10 | remainder_Expenses | 60,327,000 |
| 11 | remainder_Revenues | 30,353,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -38,004,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,933,000 |
| 1 | Liabilities | 33,145,000 |
| 2 | Expenses | 87,942,000 |
| 3 | Revenues | 30,353,000 |
| 4 | StockholdersEquity | 28,788,000 |
| 5 | NetIncome | -57,589,000 |
| 6 | ComprehensiveNetIncome | -76,591,000 |
| 7 | BaseVar | 125,688,500 |
| 8 | EconomicCapitalRatio | -0.570 |
Edgar->Model Mapping
Feature Distribution
Change over Time
